September 2008 Volume 5 Number 9
Visit Nature Clinical Practice Oncology online to browse the journal.
Now available at http://ealerts.nature.com/cgi-bin24/DM/y/enCj0Xztnp0HjM0UgF0Et
=====================================================================
Announcing the NEW British Journal of Cancer website with enhanced
functionality
Visit http://ealerts.nature.com/cgi-bin24/DM/y/enCj0Xztnp0HjM0f8c0Es and benefit
from new features, including RSS Web Feeds, Article Links and Top Ten
downloaded articles.
=====================================================================
----------------------
EDITORIAL
----------------------
Trials and tribulations
Vincent T DeVita Jr
http://ealerts.nature.com/cgi-bin24/DM/y/enCj0Xztnp0HjM0B4JQ0EA
----------------------
RESEARCH HIGHLIGHTS
----------------------
Intensity of therapy for ALL can be reduced in non-high-risk patients
http://ealerts.nature.com/cgi-bin24/DM/y/enCj0Xztnp0HjM0B4JR0EB
Extracolonic screening by CT colonography is beneficial
http://ealerts.nature.com/cgi-bin24/DM/y/enCj0Xztnp0HjM0B4JS0EC
Multiple myeloma: high-risk immunophenotypes identified
http://ealerts.nature.com/cgi-bin24/DM/y/enCj0Xztnp0HjM0B4JT0ED
Simple molecular-grade gene index has prognostic value in early-stage
breast cancer
http://ealerts.nature.com/cgi-bin24/DM/y/enCj0Xztnp0HjM0B4JU0EE
Therapy with cetuximab and irinotecan in refractory metastatic colorectal
cancer
http://ealerts.nature.com/cgi-bin24/DM/y/enCj0Xztnp0HjM0B4JV0EF
Weekly adjuvant paclitaxel improves survival after standard chemotherapy
in breast cancer
http://ealerts.nature.com/cgi-bin24/DM/y/enCj0Xztnp0HjM0B4JW0EG
Prostate stem cell antigen is associated with diffuse-type gastric cancer
http://ealerts.nature.com/cgi-bin24/DM/y/enCj0Xztnp0HjM0B4JX0EH
Common single nucleotide polymorphisms are linked to neuroblastoma
http://ealerts.nature.com/cgi-bin24/DM/y/enCj0Xztnp0HjM0B4JY0EI
Increased c-kit expression predicts poor outcome in acute myeloid leukemia
http://ealerts.nature.com/cgi-bin24/DM/y/enCj0Xztnp0HjM0B4JZ0EJ
High BAALC expression is indicative of poor survival in acute myeloid
leukemia
http://ealerts.nature.com/cgi-bin24/DM/y/enCj0Xztnp0HjM0B4Ja0EQ
Extent of poorly differentiated carcinoma is an effective grading tool
http://ealerts.nature.com/cgi-bin24/DM/y/enCj0Xztnp0HjM0B4Jb0ER
Identification of malignant thyroid tumors by differential gene expression
http://ealerts.nature.com/cgi-bin24/DM/y/enCj0Xztnp0HjM0B4Jc0ES
Family history influences post-treatment survival in patients with
advanced colon cancer
http://ealerts.nature.com/cgi-bin24/DM/y/enCj0Xztnp0HjM0B4Jd0ET
----------------------
PRACTICE POINTS
----------------------
Early postinduction intensification therapy is essential in childhood
acute lymphoblastic leukemia
Gunter Henze
http://ealerts.nature.com/cgi-bin24/DM/y/enCj0Xztnp0HjM0B4Je0EU
VTE and mortality associated with erythropoiesis-stimulating agents in
cancer-associated anemia
Roxana S Dronca and David P Steensma
http://ealerts.nature.com/cgi-bin24/DM/y/enCj0Xztnp0HjM0B4Jf0EV
Docetaxel chemotherapy remains the standard of care in castration-resistant
prostate cancer
Brian Schurko and William K Oh
http://ealerts.nature.com/cgi-bin24/DM/y/enCj0Xztnp0HjM0B4Jg0EW
Is the addition of cisplatin to S-1 better than S-1 alone for patients
with advanced gastroesophageal cancer?
Jaffer A Ajani
http://ealerts.nature.com/cgi-bin24/DM/y/enCj0Xztnp0HjM0B4Jh0EX
----------------------
VIEWPOINT
----------------------
The rationale for sentinel-node biopsy in primary melanoma
Donald L Morton, Alistair J Cochran and John F Thompson
http://ealerts.nature.com/cgi-bin24/DM/y/enCj0Xztnp0HjM0B4Ji0EY
----------------------
REVIEWS
----------------------
Drug Insight: intracellular inhibitors of HER2-clinical development of
lapatinib in breast cancer
David A Cameron and Steven Stein
http://ealerts.nature.com/cgi-bin24/DM/y/enCj0Xztnp0HjM0B4Jj0EZ
Combined targeting of EGFR-dependent and VEGF-dependent pathways:
rationale, preclinical studies and clinical applications
Giampaolo Tortora, Fortunato Ciardiello and Giampietro Gasparini
http://ealerts.nature.com/cgi-bin24/DM/y/enCj0Xztnp0HjM0B4Jk0Ea
The role of hormonal therapy in the management of hormonal-receptor-positive
breast cancer with co-expression of HER2
Aleix Prat and Jose Baselga
http://ealerts.nature.com/cgi-bin24/DM/y/enCj0Xztnp0HjM0B4Jl0Eb
Treatment of Hodgkin lymphoma: the past, present, and future
Andrew M Evens, Martin Hutchings and Volker Diehl
http://ealerts.nature.com/cgi-bin24/DM/y/enCj0Xztnp0HjM0B4Jm0Ec
----------------------
CASE STUDY
----------------------
CTLA-4 blockade with ipilimumab induces significant clinical benefit in
a female with melanoma metastases to the CNS
F Stephen Hodi, Darryl A Oble, Jan Drappatz, Elsa F Velazquez, Nikhil
Ramaiya, Naren Ramakrishna, Arthur L Day, Andrea Kruse, Suzanne Mac Rae,
Axel Hoos and Martin Mihm
http://ealerts.nature.com/cgi-bin24/DM/y/enCj0Xztnp0HjM0B4Jn0Ed
=====================================================================
ESO e-grandround
http://ealerts.nature.com/cgi-bin24/DM/y/enCj0Xztnp0HjM0BrPN0EF
The European School of Oncology in partnership with
Nature Clinical Practice Oncology is pleased to announce live
e-grandrounds. These online discussion-based presentations allow
participants to submit questions and take part in lively discussions.
We invite you to join the e-grandrounds, which are broadcast every
other Thursday from 17:15-18:00 GMT.
Please visit http://ealerts.nature.com/cgi-bin24/DM/y/enCj0Xztnp0HjM0BrPk0Ei
for further information.
=====================================================================
You have been sent this Table of Contents Alert because you have opted
in to receive it. You can change or discontinue your e-mail alerts at
any time, by modifying your preferences on your nature.com account at:
http://ealerts.nature.com/cgi-bin24/DM/y/enCj0Xztnp0HjM0Zzu0E5
(You will need to log in to be recognised as a nature.com registrant).
For further technical assistance, please contact our registration department:
registration@nature.com
For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com
For other enquiries, please contact our customer feedback department:
feedback@nature.com
Nature Publishing Group | 75 Varick Street, 9th Floor | New York |
NY 10013-1917 | USA
Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne -
San Diego - San Francisco - Washington - New York - Boston
=====================================================================
